Detalhe da pesquisa
1.
Carfilzomib, cyclophosphamide and dexamethasone for newly diagnosed, high-risk myeloma patients not eligible for transplant: a pooled analysis of two studies.
Haematologica
; 106(4): 1079-1085, 2021 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32107329
2.
Cyclophosphamide's addition in relapsed/refractory multiple myeloma patients with biochemical progression during lenalidomide-dexamethasone treatment.
Eur J Haematol
; 2018 May 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29719938
3.
Elotuzumab, lenalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: Italian, multicenter, retrospective clinical experience with 300 cases outside of controlled clinical trials.
Haematologica
; 106(1): 291-294, 2021 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32107338
4.
Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial.
Lancet Oncol
; 16(16): 1617-29, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-26596670
5.
Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide.
Blood
; 119(4): 933-9; quiz 1093, 2012 Jan 26.
Artigo
Inglês
| MEDLINE | ID: mdl-21835953
6.
Risk of SARS-CoV-2 infection in patients with hematologic diseases receiving tixagevimab/cilgavimab as pre-exposure prophylaxis in most recent Omicron sublineages era.
Int J Infect Dis
; 144: 107042, 2024 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-38614231
7.
Bortezomib, melphalan, and prednisone in elderly patients with relapsed/refractory multiple myeloma: a multicenter, open label phase 1/2 study.
Cancer
; 119(5): 971-7, 2013 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-23096113
8.
Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients.
Blood
; 117(11): 3025-31, 2011 Mar 17.
Artigo
Inglês
| MEDLINE | ID: mdl-21228328
9.
Successful Decitabine Treatment in Unfit, Elderly Patients with Acute Myeloid Leukemia following Chronic Myeloproliferative Neoplasm.
Acta Haematol
; 140(4): 231-233, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30384359
10.
Prognostic factors associated with progression of smoldering multiple myeloma to symptomatic form.
Cancer
; 118(22): 5544-9, 2012 Nov 15.
Artigo
Inglês
| MEDLINE | ID: mdl-22786730
11.
Advanced chronic myelomonocytic leukemia in elderly and frail patients managed by azacitidine in the field of clinical practice.
Ann Hematol
; 96(9): 1591-1593, 2017 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-28702776
12.
Daratumumab combined with dexamethasone and lenalidomide or bortezomib in relapsed/refractory multiple myeloma (RRMM) patients: Report from the multiple myeloma GIMEMA Lazio group.
EJHaem
; 3(1): 121-128, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-35846211
13.
Towards a better understanding of the relationship between side effects of analgesia and quality of life in patients with multiple myeloma.
Support Care Cancer
; 24(1): 9-10, 2016 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-26238628
14.
Pulmonary arterial hypertension in a patient with multiple myeloma during carfilzomib treatment: in search of better management.
Tumori
; 107(6): NP37-NP40, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-33525991
15.
Chronic myelomonocytic leukemia coexisting with monoclonal gammopathy: concomitant response to azacitidine of both disorders.
Ann Hematol
; 94(10): 1753-4, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-26088814
16.
Dysgeusia in patients with hematological malignancies: a reminder for hematologist.
J Oral Pathol Med
; 42(4): 352-3, 2013 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-23278835
17.
Early mortality in myeloma patients treated with first-generation novel agents thalidomide, lenalidomide, bortezomib at diagnosis: A pooled analysis.
Crit Rev Oncol Hematol
; 130: 27-35, 2018 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-30196909
18.
Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials.
Crit Rev Oncol Hematol
; 132: 9-16, 2018 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-30447931
19.
Infection complications in an unselected cohort of patients with multiple myeloma treated with lenalidomide combinations.
Eur J Haematol
; 89(3): 276-7, 2012 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-22672700
20.
Safety and efficacy of a combination therapy with Revlimid, Adriamycin and dexamethasone (RAD) in relapsed/refractory multiple myeloma (MM): a single-centre experience.
Ann Hematol
; 90(1): 115-6, 2011 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-20422414